LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.50 | 770.25 | 5959 | 10991 | 0.5421 | 0.7049 | MN20160304_L02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.50 | 770.25 | 7057 | 10991 | 0.6420 | 0.7818 | MN20160304_L02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.50 | 770.25 | 6475 | 10991 | 0.5891 | 0.7422 | MN20160304_L02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.75 | 770.25 | 6171 | 11262 | 0.5479 | 0.7120 | MN20160304_L02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.75 | 770.25 | 7276 | 11262 | 0.6460 | 0.7865 | MN20160304_L02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.75 | 770.25 | 6781 | 11262 | 0.6021 | 0.7543 | MN20160304_L02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 78.98 | 770.25 | 6462 | 11518 | 0.5610 | 0.7247 | MN20160304_L02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 78.98 | 770.25 | 7576 | 11518 | 0.6577 | 0.7964 | MN20160304_L02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 78.98 | 770.25 | 7123 | 11518 | 0.6184 | 0.7683 | MN20160304_L02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 81.20 | 770.25 | 6749 | 11766 | 0.5736 | 0.7364 | MN20160304_L02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 81.20 | 770.25 | 7836 | 11766 | 0.6660 | 0.8036 | MN20160304_L02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 81.20 | 770.25 | 7302 | 11766 | 0.6206 | 0.7715 | MN20160304_L02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 83.42 | 770.25 | 7100 | 12031 | 0.5901 | 0.7509 | MN20160304_L02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 83.42 | 770.25 | 8191 | 12031 | 0.6808 | 0.8152 | MN20160304_L02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 83.42 | 770.25 | 7698 | 12031 | 0.6398 | 0.7870 | MN20160304_L02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 85.64 | 770.25 | 7464 | 12287 | 0.6075 | 0.7654 | MN20160304_L02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 85.64 | 770.25 | 8483 | 12287 | 0.6904 | 0.8229 | MN20160304_L02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 85.64 | 770.25 | 8036 | 12287 | 0.6540 | 0.7984 | MN20160304_L02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 87.86 | 770.25 | 7747 | 12543 | 0.6176 | 0.7744 | MN20160304_L02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 87.86 | 770.25 | 8752 | 12543 | 0.6977 | 0.8289 | MN20160304_L02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 87.86 | 770.25 | 8217 | 12543 | 0.6551 | 0.8005 | MN20160304_L02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 3.21 | 770.25 | 902 | 904 | 0.9971 | 0.9751 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 3.21 | 770.25 | 867 | 904 | 0.9584 | 0.6654 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 5.44 | 770.25 | 1022 | 1012 | 1.0091 | 1.0466 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 5.44 | 770.25 | 928 | 1012 | 0.9163 | 0.6029 | MN20160304_L02 | F12 |